These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 23475599)

  • 21. Extra-esophageal gastroesophageal reflux disease and asthma: understanding this interplay.
    Naik RD; Vaezi MF
    Expert Rev Gastroenterol Hepatol; 2015 Jul; 9(7):969-82. PubMed ID: 26067887
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical role of ambulatory reflux monitoring in PPI non-responders: recommendation statements.
    Yadlapati R; Gawron AJ; Gyawali CP; Chen J; Clarke J; Fass R; Jain A; Lynch K; Khan A; Katz PO; Katzka DA; Richter J; Schnoll-Sussman F; Spechler SJ; Vaezi MF; Vela M; Pandolfino JE
    Aliment Pharmacol Ther; 2022 Oct; 56(8):1274-1283. PubMed ID: 35971888
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gastroesophageal reflux disease: exaggerations, evidence and clinical practice.
    Ferreira CT; Carvalho Ed; Sdepanian VL; Morais MB; Vieira MC; Silva LR
    J Pediatr (Rio J); 2014; 90(2):105-18. PubMed ID: 24184302
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Many patients continue using proton pump inhibitors after negative results from tests for reflux disease.
    Gawron AJ; Rothe J; Fought AJ; Fareeduddin A; Toto E; Boris L; Kahrilas PJ; Pandolfino JE
    Clin Gastroenterol Hepatol; 2012 Jun; 10(6):620-5; quiz e57. PubMed ID: 22366177
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The proton pump inhibitor test and the diagnosis of gastroesophageal reflux disease.
    Pace F; Pace M
    Expert Rev Gastroenterol Hepatol; 2010 Aug; 4(4):423-7. PubMed ID: 20678016
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Refractory gastroesophageal reflux disease: advances and treatment.
    Ates F; Francis DO; Vaezi MF
    Expert Rev Gastroenterol Hepatol; 2014 Aug; 8(6):657-67. PubMed ID: 24745809
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Algorithmic approach to patients presenting with heartburn and epigastric pain refractory to empiric proton pump inhibitor therapy.
    Roorda AK; Marcus SN; Triadafilopoulos G
    Dig Dis Sci; 2011 Oct; 56(10):2871-8. PubMed ID: 21512760
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The value of early wireless esophageal pH monitoring in diagnosing functional heartburn in refractory gastroesophageal reflux disease.
    Park EY; Choi MG; Baeg M; Lim CH; Kim J; Cho Y; Park J; Lee I; Kim S; Choi K
    Dig Dis Sci; 2013 Oct; 58(10):2933-9. PubMed ID: 23765257
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reflux monitoring: on or off therapy?
    Vaezi MF
    Am J Gastroenterol; 2011 Feb; 106(2):183-5. PubMed ID: 21301447
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Insufficient symptom control under long-term treatment with PPI in GERD - fact or fiction?].
    Labenz J; Labenz G; Stephan D; Willeke F;
    MMW Fortschr Med; 2016 May; 158 Suppl 4():7-11. PubMed ID: 27221555
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Advances in the diagnosis of GERD.
    Săraru ER; Enciu V; Peagu R; Fierbinţeanu-Braticevici C
    Rom J Intern Med; 2021 Mar; 59(1):3-9. PubMed ID: 33010143
    [TBL] [Abstract][Full Text] [Related]  

  • 32. GERD assessment including pH metry predicts a high response rate to PPI standard therapy.
    Kandulski A; Peitz U; Mönkemüller K; Neumann H; Weigt J; Malfertheiner P
    BMC Gastroenterol; 2013 Jan; 13():12. PubMed ID: 23324360
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Management of gastroesophageal reflux disease that does not respond well to proton pump inhibitors.
    Hershcovici T; Fass R
    Curr Opin Gastroenterol; 2010 Jul; 26(4):367-78. PubMed ID: 20571388
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The diagnosis of gastroesophageal reflux disease.
    Dughera L; Navino M; Cassolino P; Pellicano R
    Minerva Gastroenterol Dietol; 2007 Jun; 53(2):143-52. PubMed ID: 17557042
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Extra-esophageal manifestations of gastroesophageal reflux disease: diagnosis and treatment.
    Hom C; Vaezi MF
    Drugs; 2013 Aug; 73(12):1281-95. PubMed ID: 23881666
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of the degree of duodenogastroesophageal reflux and acid reflux between patients who failed to respond and those who were successfully treated with a proton pump inhibitor once daily.
    Gasiorowska A; Navarro-Rodriguez T; Wendel C; Krupinski E; Perry ZH; Koenig K; Moty B; Powers J; Fass R
    Am J Gastroenterol; 2009 Aug; 104(8):2005-13. PubMed ID: 19491829
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Current issues on gastroesophageal reflux disease].
    Kim JH; Kim BJ; Kim SW; Kim SE; Kim YS; Sung HY; Oh TH; Jeong ID; Park MI; ;
    Korean J Gastroenterol; 2014 Sep; 64(3):127-32. PubMed ID: 25252860
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Laboratory based investigations for diagnosing gastroesophageal reflux disease.
    Dolder M; Tutuian R
    Best Pract Res Clin Gastroenterol; 2010 Dec; 24(6):787-98. PubMed ID: 21126694
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Predictors of proton pump inhibitor failure in non-erosive reflux disease: A study with impedance-pH monitoring and high-resolution manometry.
    Shi Y; Tan N; Zhang N; Xiong L; Peng S; Lin J; Chen M; Xiao Y
    Neurogastroenterol Motil; 2016 May; 28(5):674-9. PubMed ID: 26768192
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Post-reflux swallow-induced peristaltic wave index and mean nocturnal baseline impedance predict PPI response in GERD patients with extra esophageal symptoms.
    Ribolsi M; Guarino MPL; Tullio A; Cicala M
    Dig Liver Dis; 2020 Feb; 52(2):173-177. PubMed ID: 31623954
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.